SAN DIEGO, April 16, 2025 /PRNewswire/ -- NEUVOGEN, Inc., a San Diego based biotechnology company with a next-generation cancer vaccine platform, announced today the ...

MD Anderson Cancer Center on Thursday launched the James P. Allison Institute, a new research hub that aims to expand the benefits of immunotherapy to more patients and different types of cancers.

HOUSTON ― The University of Texas MD Anderson Cancer Center today launched the James P. Allison Institute, a visionary research and innovation hub within MD Anderson designed to foster groundbreaking ...

Please provide your email address to receive an email when new articles are posted on . The University of Texas MD Anderson Cancer announced Thursday the launch of the James P. Allison Institute, a ...

HOUSTON ― The James P. Allison Institute at The University of Texas MD Anderson Cancer Center today announced the appointment of its first members, James P. Allison ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min An institute at MD Anderson ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--InterVenn Biosciences today announced that Nobel Prize recipient, James P. Allison, has joined the company’s Board of Advisors, effective March 9, 2021.

The 2015 Pezcoller Foundation-American Association for Cancer Research (AACR) International Award for Cancer Research will be presented to James P. Allison, PhD, at the AACR Annual Meeting 2015, to be ...

CAMBRIDGE, Mass., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and ...

HOUSTON – The University of Texas MD Anderson Cancer Center announced Thursday the launch of James P. Allison Institute, a hub within MD Anderson, aimed at advancing immunotherapy treatments. The ...